{
  "url": "https://voxday.net/2022/01/25/ivermectin-vs-the-vaxx/",
  "scraped_at": "2026-01-08T13:07:40.052009",
  "title": "Ivermectin vs the Vaxx",
  "date_display": "January 25, 2022",
  "date_iso": "2022-01-25T13:26:00+00:00",
  "date_from_url": "2022-01-25",
  "author": "VD",
  "content_html": "<div class=\"entry-content\"><p>The conclusive verdict is in courtesy of a very large and peer-reviewed Brazilian study: Ivermectin is, and always was, <a href=\"https://flccc.substack.com/p/large-peer-reviewed-research-study\">a much safer and effective approach</a> to combating Covid-19 than the various vaxxines.</p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>Researchers in Brazil found that regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization and mortality rates.</p><p>The study was conducted in Itajaí, a port city in the state of Santa Catarina, between July and December 2020. Study authors include FLCCC physicians Dr. Flavio Cadegiani and Dr. Pierre Kory. Lead author Dr. Lucy Kerr was approached by the mayor of Itajaí, after the city began to experience a severe outbreak of COVID.</p><p>The entire population of Itajaí was invited to participate in the program, which involved a medical visit to compile baseline, personal, demographic, and medical information. In the absence of contraindications, ivermectin was offered as a preventative treatment, to be taken for two consecutive days every 15 days at a dose of 0.2 mg/kg/day.</p><p>Of the 223,128 citizens of Itajaí considered for the study, a total of 159,561 subjects elected to participate: over 70% opted to take ivermectin, and 23% chose not to.</p><p>The study found a 44% reduction in COVID-19 infection rate in favor of the group that took ivermectin (3.5% versus 8.2%).</p><p>In cases where a participating citizen of Itajaí became ill with COVID-19, they were recommended not to use ivermectin or any other medication in early outpatient treatment. Of those who did become infected, two equal-sized, highly matched groups (one that used ivermectin as a prophylaxis and one that did not) were compared. The regular use of preventative ivermectin led to a 68% reduction in COVID-19 mortality (0.8% versus 2.6%), and a 56% reduction in hospitalization rate (1.6% versus 3.3%).</p></blockquote><p>Meanwhile, a small, non-peer reviewed, but nevertheless informative survey of two high school coaches reveals some remarkable negative consequences for young athletes who are vaccinated:</p><p>The two coaches, who spoke to us on condition of anonymity for all involved, retrospectively observed the following of the COVID-vaccinated student athletes, and we report their findings in this retrospective study.</p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>1) None of the vaccinated student athletes are competing up to their own previous level; all are performing worse than in 2020, in the assessments of the two coaches.</p><p>2) None of the vaccinated student athletes can endure the same exercise drills for the same amount of time that they used to tolerate prior to vaccination.</p><p>3) Recovery from exertion took longer in the vaccinated student athletes than before vaccination and took longer than in the unvaccinated.</p><p>4) After the injections, most or all of the vaccinated student athletes talked about one or more of the following reactions after vaccination:</p><p>a) chest pain;</p><p>b) dizziness;</p><p>c) seeing stars;</p><p>d) feeling as if they would faint;</p><p>e) shortness of breath.</p><p>The student athletes talked freely and spontaneously about the above symptoms without anyone taking notes at the time. There was no prompting from coaches about reporting of symptoms.</p><p>5) The unvaccinated girls are now beating vaccinated boys in competition, whom they could not do well against last year. This change was unexpected and was considered unusual by the coaches.</p></blockquote><p>So, whatever happened to “trusting the science”?</p><p><em><a href=\"https://social.infogalactic.com/micropost/865ad992-c6fd-4f31-9b14-56fda9741fc2\">DISCUSS ON SG</a></em></p></div>",
  "content_text": "The conclusive verdict is in courtesy of a very large and peer-reviewed Brazilian study: Ivermectin is, and always was,\na much safer and effective approach\nto combating Covid-19 than the various vaxxines.\nResearchers in Brazil found that regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization and mortality rates.\nThe study was conducted in Itajaí, a port city in the state of Santa Catarina, between July and December 2020. Study authors include FLCCC physicians Dr. Flavio Cadegiani and Dr. Pierre Kory. Lead author Dr. Lucy Kerr was approached by the mayor of Itajaí, after the city began to experience a severe outbreak of COVID.\nThe entire population of Itajaí was invited to participate in the program, which involved a medical visit to compile baseline, personal, demographic, and medical information. In the absence of contraindications, ivermectin was offered as a preventative treatment, to be taken for two consecutive days every 15 days at a dose of 0.2 mg/kg/day.\nOf the 223,128 citizens of Itajaí considered for the study, a total of 159,561 subjects elected to participate: over 70% opted to take ivermectin, and 23% chose not to.\nThe study found a 44% reduction in COVID-19 infection rate in favor of the group that took ivermectin (3.5% versus 8.2%).\nIn cases where a participating citizen of Itajaí became ill with COVID-19, they were recommended not to use ivermectin or any other medication in early outpatient treatment. Of those who did become infected, two equal-sized, highly matched groups (one that used ivermectin as a prophylaxis and one that did not) were compared. The regular use of preventative ivermectin led to a 68% reduction in COVID-19 mortality (0.8% versus 2.6%), and a 56% reduction in hospitalization rate (1.6% versus 3.3%).\nMeanwhile, a small, non-peer reviewed, but nevertheless informative survey of two high school coaches reveals some remarkable negative consequences for young athletes who are vaccinated:\nThe two coaches, who spoke to us on condition of anonymity for all involved, retrospectively observed the following of the COVID-vaccinated student athletes, and we report their findings in this retrospective study.\n1) None of the vaccinated student athletes are competing up to their own previous level; all are performing worse than in 2020, in the assessments of the two coaches.\n2) None of the vaccinated student athletes can endure the same exercise drills for the same amount of time that they used to tolerate prior to vaccination.\n3) Recovery from exertion took longer in the vaccinated student athletes than before vaccination and took longer than in the unvaccinated.\n4) After the injections, most or all of the vaccinated student athletes talked about one or more of the following reactions after vaccination:\na) chest pain;\nb) dizziness;\nc) seeing stars;\nd) feeling as if they would faint;\ne) shortness of breath.\nThe student athletes talked freely and spontaneously about the above symptoms without anyone taking notes at the time. There was no prompting from coaches about reporting of symptoms.\n5) The unvaccinated girls are now beating vaccinated boys in competition, whom they could not do well against last year. This change was unexpected and was considered unusual by the coaches.\nSo, whatever happened to “trusting the science”?\nDISCUSS ON SG",
  "tags": [
    "science",
    "vaccines"
  ],
  "categories": [],
  "sitemap_lastmod": "2022-01-25T20:27:27+00:00"
}